ScandiDos (SDOS.ST) Stock Price

ScandiDos Price

CLOSED
0.60
​
Market closed

Over the last 15 years ScandiDos grew revenue by 4.3% annually, reaching 54.22 M SEK. For ScandiDos, the net margin of -6.3% is up versus -12.7% a few years ago.

ScandiDos stock price

Access this data via the Eulerpool API

ScandiDos business model & stock analysis

ScandiDos AB is a leading company in the field of medical technology based in Uppsala, Sweden. The company was founded in 2002 and specializes in the development of innovative solutions for radiation therapy. ScandiDos AB is a subsidiary of ScandiDos Inc., a US-based company located in Madison, Wisconsin. The business model of ScandiDos AB is based on the development of high-quality, innovative products for radiation therapy and the provision of excellent services for customers. The company focuses on the needs of doctors, medical professionals, and patients, with the goal of constantly optimizing and improving the quality of radiation therapy. ScandiDos AB is divided into different divisions that focus on the specific requirements and needs of customers. One of these divisions is the development of advanced dosimeters for radiation therapy. ScandiDos AB's dosimeters are world-leading and can provide fast and precise real-time measurement of the radiation dose. They are designed for use in the radiation therapy of cancer patients and can ensure that patients receive an effective dosage that fights tumor growth while sparing the surrounding tissue. Another important division of ScandiDos AB is the provision of training and support for customers. The company offers a wide range of training, courses, and support for doctors, business partners, and medical professionals to ensure that customers have the necessary knowledge and skills to effectively use and utilize ScandiDos AB's dosimeters and other products. The training is conducted by experienced specialists and tailored to the specific needs of customers. ScandiDos AB's product range also includes specialized software tools for radiation therapy. This includes, for example, the Delta4® Phantom simulator, which allows for a simulation of radiation therapy to achieve the best results. In addition, ScandiDos AB offers other software tools for measuring and monitoring the radiation dose. ScandiDos AB has an extensive network of international partners and business associates who support the company in providing its products and services. The partners are represented in various countries worldwide and ensure that ScandiDos AB's products and services are available everywhere in the world. Overall, ScandiDos AB has become a company that focuses on quality, innovation, and customer satisfaction. The company's products and services contribute to improving the results of radiation therapy and increasing the quality of life for cancer patients worldwide.

Frequently asked questions about ScandiDos

ScandiDos AB operates with a business model focused on the development and provision of advanced quality assurance solutions for radiation therapy. The company aims to improve patient safety and treatment accuracy by offering innovative and reliable products. ScandiDos AB's portfolio includes the Delta4 Phantom+ system, which enables precise measurements of radiation doses delivered during cancer treatments. By continuously refining their product offerings and collaborating with leading radiation therapy centers, ScandiDos AB strives to enhance treatment quality and facilitate the advancement of cancer care.

ScandiDos AB is primarily active in the healthcare industry.

The main competitors of ScandiDos AB in the market include Varian Medical Systems, Elekta AB, and Sun Nuclear Corporation. These companies also specialize in the development and manufacturing of advanced radiation therapy quality assurance solutions, similar to ScandiDos AB. However, ScandiDos AB stands out with its innovative technologies and products, such as the world-renowned Delta4 system. With its commitment to delivering accurate and reliable quality assurance solutions, ScandiDos AB continues to compete effectively in the market, gaining recognition and trust from customers worldwide.

ScandiDos AB, a renowned Swedish company, boasts a rich history and background. Established in [insert year], ScandiDos AB has become a leading player in the field of quality assurance solutions for modern radiation therapy. Throughout its journey, the company has revolutionized the medical industry by offering advanced radiation measuring systems and software, ensuring accurate and safe cancer treatments. With a strong commitment to innovation and research, ScandiDos AB continually pioneers cutting-edge technologies that enhance patient care and treatment outcomes. Today, ScandiDos AB stands as a globally recognized name, trusted by medical professionals worldwide for its exceptional contributions to radiation therapy.

ScandiDos AB, a renowned stock company, has achieved remarkable milestones throughout its journey. The company has established itself as a leader in the field of advanced quality assurance systems for radiotherapy, revolutionizing the industry. ScandiDos AB has successfully developed and deployed innovative products like Delta4, providing accurate and efficient dosimetry measurement solutions. Additionally, the company has expanded its global presence through strategic partnerships and collaborations, reinforcing its position as a trusted provider of cutting-edge technology in radiation therapy. ScandiDos AB's commitment to excellence and continuous advancements have made them a preferred choice in the industry, ensuring better patient care and treatment outcomes.

ScandiDos AB is primarily present in Sweden and the European region.

ScandiDos AB represents a strong commitment to innovation, quality, and customer satisfaction. The company believes in continuous improvement and strives to deliver cutting-edge solutions in the field of radiation therapy quality assurance. With a focus on precision and accuracy, ScandiDos AB aims to ensure the highest standards of radiation treatment planning and delivery. Their corporate philosophy revolves around providing reliable and effective tools for healthcare professionals to enhance patient safety and optimize treatment outcomes. By investing in research and development, ScandiDos AB remains dedicated to advancing the field of radiation dosimetry and improving the overall quality of cancer care.

Converted at the current exchange rate, the ScandiDos share trades at 0.05 EUR (0.60 SEK).

The company ScandiDos AB is a leading provider of diagnostic and monitoring systems for radiation therapy. The company was founded in Sweden in 2002 and has since become a global market leader. ScandiDos AB is headquartered in Uppsala, Sweden, and operates sales and service centers in the USA, Europe, and Asia. The business model of ScandiDos AB is based on the development and sale of diagnostic and monitoring systems for radiation therapy. The company offers a wide portfolio of products, including the Delta4 system for real-time monitoring of radiation dose and the Compass system for precise patient positioning during radiation therapy. The Delta4 system from ScandiDos AB is a unique monitoring system that measures and monitors the radiation dose in real-time during radiation therapy. It is the world's first system to deliver radiation dose at all levels of the patient, enabling fast and accurate dose monitoring. The system is used in hospitals worldwide and is appreciated by radiation therapists and medical physicists alike. The Compass system from ScandiDos AB is a precise positioning system that ensures the patient is in the correct position and does not move during radiation therapy. The system uses automatic and continuous monitoring technology to monitor the patient's position throughout the entire radiation therapy session. This allows for precise and effective radiation therapy. Other products from ScandiDos AB include the Solo system for monitoring radiation dose in individual sessions and the ArcCheck system for control and monitoring of beam shape in arc radiation. ScandiDos AB also has a strong service business, offering its customers technical support and training programs. The company works closely with its customers to ensure they can effectively use ScandiDos AB's products and services. ScandiDos AB has developed a range of tailored training programs for its customers, including individual and group training. Overall, ScandiDos AB's business model is focused on offering high-quality and innovative products and services that enable medical professionals to provide precise and effective radiation therapy. The company aims to improve radiation therapy and provide patients with better treatment and healing prospects.

The revenue of ScandiDos is 54.22 M SEK. This figure is based on current financial data and reflects the company's business performance.

The profit of ScandiDos is -3.44 M SEK. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of ScandiDos is currently -9.96. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the ScandiDos stock.

The price-to-sales ratio (P/S) of ScandiDos is currently 0.63. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the ScandiDos stock.

The Eulerpool Quality Score for ScandiDos is 2/10.

The ISIN of ScandiDos is SE0005768124. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of ScandiDos is A112AF. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of ScandiDos is SDOS.ST. The ticker symbol is used to trade ScandiDos shares on the stock exchange.

Fair ValueTerminal
0.50 SEK
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
1.64 M SEK
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Sweden
Currency
SEK
Initial public offering
Apr 11, 2014
ISIN
SE0005768124
Cusip
W7T14M104
Sedol
BLM77D7
Market capitalization
34.21 M SEKMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.82
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-8.24 %
Last updated Oct 9, 2026, 4:36 AM

ScandiDos FIGI

SDOS:SF · BBG0069KHL07SDOSSEK:EO · BBG006B8W2K4SDOSSEK:XH · BBG006B8W2N1SDOSSEK:XF · BBG006B8W2Q8SDOSSEK:XE · BBG006B8W2S6SDOSSEK:XJ · BBG006B8W2T5SDOSSEK:XL · BBG006B8W2V2SDOSSEK:XG · BBG006B8W2W1SDOSSEK:XO · BBG006B8W2X0SDOSSEK:XS · BBG006B8W313SDOSSEK:XA · BBG006B8W322SDOSSEK:E1 · BBG006B8W331